Springer’s Journal of Pharmacokinetics and Pharmacodynamics
announces an affiliation with the American Society of Pharmacometrics (ASoP) starting in 2012. Publishing six issues per year, the journal presents cutting-edge research for pharmaceutical scientists in industry and academia. The publication was launched in 1973 and had an impact factor (IF) of 1.708 in 2010.
The Journal of Pharmacokinetics and Pharmacodynamics
is devoted to illustrating the importance of pharmacokinetics, pharmacodynamics, and pharmacometrics in the understanding of drug action, therapy, design, development and evaluation. Most papers published illustrate and apply their findings to real-world observations in animals and/or humans. The journal will also include proceedings of the Society’s annual meeting. The editor-in-chief is William J. Jusko, PhD from the University of Buffalo, State University of New York, USA.
Stacey Tannenbaum, President of ASoP, said, “I am delighted with the Society’s affiliation with Springer, establishing the Journal of Pharmacokinetics and Pharmacodynamics
as an official publication of the American Society of Pharmacometrics. This partnership between ASoP and the journal will further promote the central role of pharmacometrics in advancing the discovery, development and utilization of new medicines for the treatment and prevention of disease to improve human health and well-being.”
Carolyn Honour, Editorial Director Biomedicine at Springer, said, “Springer is happy to welcome ASoP as a collaborative partner for one of the leading journals in pharmaceutical science. We see this relationship as a pivotal step in the Society’s mission to advance pharmacometrics, and we look forward to being able to provide worldwide access to the high-value content originating from this dynamic field.”
The goal of the American Society of Pharmacometrics
(ASoP) is to promote the discipline of pharmacometrics, broaden its impact through scientific innovation, advance the integration of knowledge and skills across disciplines, and foster a positive impact on biomedical R & D. The society offers a central organization for the integration of national and international pharmacometrics communities, initiatives, consortia and educational activities. It actively partners with other scientific and medical disciplines and organizations.Springer
(www.springer.com) is a leading global scientific publisher of books and journals, delivering quality content through innovative information products and services. It publishes close to 500 academic and professional society journals. Springer is part of the publishing group Springer Science+Business Media. In the science, technology and medicine (STM) sector, the group publishes around 2,000 journals and more than 7,000 new books a year, as well as the largest STM eBook Collection worldwide. Springer has operations in about 20 countries in Europe, the USA, and Asia, and more than 5,500 employees.